/
Amendments · SAMDT 5336
FAILED· 119TH CONGRESS· SENATE
Senate AmendmentSAMDT 5336
To establish a deficit-neutral reserve fund relating to requiring the Comptroller General of the United States to conduct a study related to economic consequences of private or confidential drug pricing agreements struck by any Federal department, agency, or office with any pharmaceutical manufacturer.
PROPOSED APR 23· LAST ACTION APR 23
- Amendment, not the bill
- Failed — base text stands
- Effect depends on parent bill
DISPOSITION
FAILED
APR 23
“Amendment SA 5336 not agreed to in Senate by Yea-Nay Vote. 48 - 50. Record Vote Number: 103.”
OTHER AMENDMENTS TO THIS BILL
- SAMDT 5333To establish a deficit-neutral reserve fund relating to requiring the obligation of amounts appropriated to the Federal …FAILED
- SAMDT 5235To establish a deficit-neutral reserve fund relating to the impacts of hedge fund ownership of single-family homes and r…FAILED
- SAMDT 5001To create a point of order against legislation that would not decrease home electricity bills.FAILED
- SAMDT 5159To reduce the price of prescription drugs in the United States by more than 50 percent by adopting Most Favored Nation d…FAILED
- SAMDT 4794To establish a deficit-neutral reserve fund relating to extending the prohibition on Medicaid payments to abortion provi…FAILED
§ 03
SUMMARY
WHAT THIS CHANGES
The parent bill sets the overall spending levels for the federal government for the next decade. This amendment creates a way to fund a nonpartisan study on how secret drug pricing deals between federal agencies and pharmaceutical companies impact the economy.
§ 04
KEY POINTS
2POINT 01
Requires a study by the Comptroller General on confidential drug pricing deals
This would provide lawmakers with data on the economic effects of government drug negotiations that are currently hidden from public view.
POINT 02
Establishes a deficit-neutral reserve fund for this purpose
This ensures that any money spent on the study or related policy changes must be offset so it does not increase the national debt.
§ 05
SPONSORSHIP
1 + 0
D· Oregon
§ 06
ACTION TIMELINE
7 EVENTSAPR 23
Amendment SA 5336 not agreed to in Senate by Yea-Nay Vote. 48 - 50. Record Vote Number: 103.
APR 23
Amendment SA 5336 proposed by Senator Wyden. (consideration: CR S1917)
APR 23
Senate amendment proposed (on the floor): Amendment SA 5336 proposed by Senator Wyden.
§ 07
AMENDMENT INFO
TypeSenate Amendment
NumberSAMDT 5336
Congress119th
ChamberSenate
StatusFAILED
ProposedApr 23, 2026
SubmittedApr 22, 2026
Last actionApr 23, 2026
§ 09
READER REACTIONS
OVERALL SENTIMENT
No reactions yet. Be the first to weigh in.
Discussion
Loading comments...
FAILED· 119TH CONGRESS · SENATE · PROPOSED APR 23, 2026
Senate AmendmentSAMDT 5336
To establish a deficit-neutral reserve fund relating to requiring the Comptroller General of the United States to conduct a study related to economic consequences of private or confidential drug pricing agreements struck by any Federal department, agency, or office with any pharmaceutical manufacturer.
PROPOSED APR 23, 2026· SUBMITTED APR 22, 2026· LAST ACTION APR 23, 2026
DISPOSITION
FAILED
COSPONSORS
0
DAYS SINCE ACTION
154
